CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Koji Shinoda, Yasunobu Yoshikai

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)111-112
Number of pages2
JournalClinical and Experimental Neuroimmunology
Volume6
Issue number2
DOIs
Publication statusPublished - May 1 2015

Fingerprint

CD30 Ligand
Autoimmunity
Central Nervous System
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

Cite this

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity. / Shinoda, Koji; Yoshikai, Yasunobu.

In: Clinical and Experimental Neuroimmunology, Vol. 6, No. 2, 01.05.2015, p. 111-112.

Research output: Contribution to journalComment/debate

@article{ae7036e05c5f4dd799659c3f4964489c,
title = "CD30 ligand could be a new therapeutic target for central nervous system autoimmunity",
author = "Koji Shinoda and Yasunobu Yoshikai",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/cen3.12204",
language = "English",
volume = "6",
pages = "111--112",
journal = "Clinical and Experimental Neuroimmunology",
issn = "1759-1961",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

AU - Shinoda, Koji

AU - Yoshikai, Yasunobu

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84928952597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928952597&partnerID=8YFLogxK

U2 - 10.1111/cen3.12204

DO - 10.1111/cen3.12204

M3 - Comment/debate

VL - 6

SP - 111

EP - 112

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

IS - 2

ER -